MYD88 mutation status does not impact overall survival in Waldenström macroglobulinemia

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-8652|93|2|187-194

ISSN： 0361-8609

Source： AMERICAN JOURNAL OF HEMATOLOGY, Vol.93, Iss.2, 2018-02, pp. : 187-194

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MYD88 wild‐type Waldenstrom Macroglobulinaemia: differential diagnosis, risk of histological transformation, and overall survival

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 3, 2018-02 ,pp. : 374-380

John Wiley & Sons Inc

Access to resources Recommend Favorite

Survival outcomes of secondary cancers in patients with waldenström macroglobulinemia: An analysis of the SEER database

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 8, 2015-08 ,pp. : 696-701

John Wiley & Sons Inc

Access to resources Recommend Favorite

CXCR4 WHIM‐like frameshift and nonsense mutations promote ibrutinib resistance but do not supplant MYD88L265P‐directed survival signalling in Waldenström macroglobulinaemia cells

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 5, 2015-03 ,pp. : 701-707

John Wiley & Sons Inc

Access to resources Recommend Favorite

Extramedullary Waldenström macroglobulinemia

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 2, 2015-02 ,pp. : 100-104

John Wiley & Sons Inc

Access to resources Recommend Favorite

MYD88 mutations can be used to identify malignant pleural effusions in Waldenström macroglobulinaemia

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 4, 2018-02 ,pp. : 578-581

John Wiley & Sons Inc

Access to resources Recommend Favorite